Showing results (101-110 of 201) with videos related to

Sort By:
Pageof 21
Bone Marrow Transplantation|April 1, 1994
Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantationD Przepiorka, C Ippoliti, A Panina, et al.
Bone Marrow Transplantation|May 1, 1996
Results with high-dose chemotherapy and unpurged autologous stem cell transplantation in 73 patients with chronic myelogenous leukemia: the MD Anderson experienceI F Khouri, H M Kantarjian, M Talpaz, et al.
Cytokines and Molecular Therapy|June 1, 1995
Interferon-alpha and interleukin-2 as treatment for leukemia relapse after allogeneic bone marrow transplantationS Giralt, S O'Brien, M Talpaz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 1999
Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipientsQ Nguyen, R Champlin, S Giralt, et al.
Bone Marrow Transplantation|June 7, 2005
Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemiaC Hosing, R M Saliba, M Shahjahan, et al.
The New England Journal of Medicine|September 9, 1993
Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantationS Giralt, S Escudier, H Kantarjian, et al.
Bone Marrow Transplantation|April 1, 2003
Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and resultsN Apisarnthanarax, M Donato, M Körbling, et al.
Bone Marrow Transplantation|October 6, 1997
Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovirC Ippoliti, A Morgan, D Warkentin, et al.
Bone Marrow Transplantation|October 6, 2000
Donor leukocyte infusions in acute lymphocytic leukemiaR H Collins, S Goldstein, S Giralt, et al.
Blood|October 15, 1993
Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myelomaM A Dimopoulos, R Alexanian, D Przepiorka, et al.
Pageof 21